Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Eligibility Criteria To qualify for Tirzepatide treatment, patients typically need a BMI of 27 or higher
Novo Nordisk has added ileus to the Postmarketing Experience section of the Wegovy label under Gastrointestinal Disorders. In October 2025, Severe Gastrointestinal Adverse Reactions was added to the WARNING AND PRECAUTIONS section of the label
The 10mg vial represents their entry-level option
Warnings & Side Effects
The appropriate response depends on how much time has passed since your scheduled injection
US$ 27.04
US$ 28.57
:max_bytes(150000):strip_icc()/not-eating-signs-symptoms-5201896_final-c41f6a10844343059195cfb13e561098.jpg)
US$ 20.68
